![M. Alexander Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Alexander Shaw
Keine laufenden Positionen mehr
Profil
M.
Alexander Shaw formerly worked at Prolifagen, Inc., as Chief Executive Officer and Nuventra, Inc., as Chief Operating Officer from 2009 to 2021.
Dr. Shaw received his undergraduate degree from Duke University and doctorate degree from Washington State University.
Ehemalige bekannte Positionen von M. Alexander Shaw
| Unternehmen | Position | Ende |
|---|---|---|
Nuventra, Inc.
 Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Geschäftsführer | 01.10.2021 |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Vorstandsvorsitzender | - |
Ausbildung von M. Alexander Shaw
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Commercial Services |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
Wählen Sie MarketScreener 
